0.3987
price up icon0.10%   0.0004
after-market アフターアワーズ: .41 0.0113 +2.83%
loading
前日終値:
$0.3983
開ける:
$0.3956
24時間の取引高:
1.38M
Relative Volume:
0.57
時価総額:
$47.09M
収益:
-
当期純損益:
$-119.76M
株価収益率:
-0.2953
EPS:
-1.35
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
+19.73%
1か月 パフォーマンス:
-27.42%
6か月 パフォーマンス:
-95.27%
1年 パフォーマンス:
-90.57%
1日の値動き範囲:
Value
$0.3867
$0.4103
1週間の範囲:
Value
$0.3051
$0.4284
52週間の値動き範囲:
Value
$0.295
$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
名前
Applied Therapeutics Inc
Name
セクター
Healthcare (1154)
Name
電話
212-220-9226
Name
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
職員
35
Name
Twitter
@Applied_Tx
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
APLT's Discussions on Twitter

APLT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
APLT
Applied Therapeutics Inc
0.3987 47.09M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-23 ダウングレード William Blair Outperform → Mkt Perform
2024-12-02 ダウングレード UBS Buy → Neutral
2024-11-29 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-07-31 開始されました William Blair Outperform
2024-03-26 開始されました RBC Capital Mkts Outperform
2024-02-22 開始されました Leerink Partners Outperform
2022-01-04 ダウングレード Barclays Overweight → Equal Weight
2021-08-27 ダウングレード Goldman Neutral → Sell
2021-06-25 再開されました Goldman Neutral
2020-10-08 開始されました Truist Buy
2020-04-22 開始されました Goldman Buy
2020-02-27 開始されました Barclays Overweight
2019-06-10 開始されました Citigroup Buy
2019-06-10 開始されました Cowen Outperform
2019-06-10 開始されました Robert W. Baird Outperform
すべてを表示

Applied Therapeutics Inc (APLT) 最新ニュース

pulisher
12:30 PM

Press Release Distribution & PR Platform - ACCESS Newswire

12:30 PM
pulisher
Apr 24, 2025

Applied Therapeutics Inc (NASDAQ:APLT)’s 12-Month Price Target Is Now Set At 5. - Marketing Sentinel

Apr 24, 2025
pulisher
Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 16, 2025
pulisher
Apr 15, 2025

Applied Therapeutics Reports 2024 Financial Results and Leadership Changes - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Applied Therapeutics, Inc. SEC 10-K Report - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Applied Therapeutics (APLT) Reports Lower Revenue But Reinforces Strategic Focus | APLT Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Fi - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

Applied Therapeutics earnings beat by $0.71, revenue fell short of estimates - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

Applied Therapeutics Strengthens Balance Sheet: $79.4M Cash Position Powers Drug Development Push - Stock Titan

Apr 14, 2025
pulisher
Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results | APLT Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 13, 2025

Norges Bank Acquires New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Apr 12, 2025
pulisher
Apr 10, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 04, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - MarketScreener

Apr 04, 2025
pulisher
Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Applied Therapeutics, Inc. (APLT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 02, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 01, 2025

Charles Schwab Investment Management Inc. Has $600,000 Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Applied Therapeutics Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Applied Therapeutics files Form 12b-25 with SEC - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Applied Therapeutics Requests SEC Extension: What This Means for 2024 Financial Results - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

146,900 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Purchased by Swiss National Bank - Defense World

Mar 31, 2025
pulisher
Mar 22, 2025

Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 22, 2025

Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 21, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 21, 2025

APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 19, 2025

Applied Therapeutics appoints new Chief Regulatory Officer By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - citybiz

Mar 19, 2025
pulisher
Mar 19, 2025

APLT DEADLINE ALERT: Applied Therapeutics Investors have until February 18 before Expiration of the Class Action DeadlineContact BFA Law if You Lost Money - Louisiana First News

Mar 19, 2025
pulisher
Mar 19, 2025

Applied Therapeutics Names Todd Baumgartner As Chief Regulatory Officer - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Applied Therapeutics appoints new Chief Regulatory Officer - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Applied Therapeutics Strengthens Drug Approval Push With 12-Time FDA Success Veteran - Stock Titan

Mar 19, 2025
pulisher
Mar 17, 2025

Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $6.10 - MarketBeat

Mar 16, 2025
pulisher
Mar 13, 2025

Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Mar 13, 2025

Applied Therapeutics Inc (APLT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Applied Therapeutics Inc (APLT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Funtleyder Leslie D.
See Remarks
Mar 04 '25
Sale
0.44
14,502
6,381
390,459
Chinoporos Constantine
See Remarks
Mar 04 '25
Sale
0.44
447
197
271,436
Funtleyder Leslie D.
See Remarks
Feb 06 '25
Sale
0.61
22,950
14,000
404,961
Perfetti Riccardo
Chief Medical Officer
Feb 06 '25
Sale
0.61
86,078
52,508
900,775
Chinoporos Constantine
See Remarks
Feb 06 '25
Sale
0.61
28,117
17,151
271,883
Funtleyder Leslie D.
Chief Financial Officer
Aug 22 '24
Sale
5.83
13,530
78,880
277,911
Perfetti Riccardo
Chief Medical Officer
Aug 22 '24
Sale
5.83
22,681
132,230
986,853
Shendelman Shoshana
President and CEO
Aug 13 '24
Sale
6.18
357,423
2,208,874
4,810,430
Shendelman Shoshana
President and CEO
Aug 12 '24
Sale
5.98
300,000
1,794,000
5,167,853
Shendelman Shoshana
President and CEO
Aug 14 '24
Sale
5.93
119,591
709,175
4,690,839
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):